Cystron Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 15-12-2024
- Paid Up Capital ₹ 1.10 Cr
as on 15-12-2024
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 3.40 Cr
as on 15-12-2024
- Revenue 54.59%
(FY 2021)
- Profit -979.30%
(FY 2021)
- Ebitda -164.84%
(FY 2021)
- Net Worth 345.95%
(FY 2021)
- Total Assets 28.09%
(FY 2021)
About Cystron Pharma
The Corporate was formerly known as Panchakalyani Food Products Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.10 Cr.
The company currently has active open charges totaling ₹3.40 Cr.
Venkata Anantharaju and Prathivenkateswararao serve as directors at the Company.
- CIN/LLPIN
U24100TG2011PTC075439
- Company No.
075439
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 2011
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Cystron Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Anantharaju  | Director | 10-Mar-2016 | Current |
| Prathivenkateswararao | Additional Director | 09-Mar-2022 | Current |
Financial Performance and Corporate Structure Insights of Cystron Pharma.
Cystron Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 54.59% increase. The company also saw a substantial fall in profitability, with a 979.3% decrease in profit. The company's net worth Soared by an impressive increase of 345.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cystron Pharma?
In 2021, Cystron Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Kakinada Maritime Service Providers Welfare AssociationActive 1 year 5 months
Prathivenkateswararao is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 22 Mar 2021 | ₹3.40 Cr | Open |
How Many Employees Work at Cystron Pharma?
Unlock and access historical data on people associated with Cystron Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cystron Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cystron Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
